C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2011
11/30/2011	CN1984655B 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂 P2y1 receptors urea useful in the treatment of thrombotic diseases antagonists
11/30/2011	CN102264703A 作为β2肾上腺素受体促效剂的5-(2-{[6-(2，2-二氟-2-苯基乙氧基)己基]胺基}-1-羟乙基)-8-羟基喹啉-2(1H)-酮的甲磺酸盐 As a β2 adrenergic receptor agonist 5- (2 - {[6- (2,2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8- hydroxyquinoline -2 (1H) - one methanesulfonate
11/30/2011	CN102260492A 喹诺酮衍生物作为oled发射材料在有机电致发光器件中的应用 Carbostyril derivative as oled emitting material in the organic electroluminescent device of Application
11/30/2011	CN102260290A 喹喏啉酮类化合物及其在制备精神病药物中的用途 Quinoxalin-ketones and their use in the preparation of psychiatric drugs
11/30/2011	CN102260210A 蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物的制备方法 Protein kinase inhibitors and histone deacetylase inhibitors of the enzyme preparation of amide derivatives of naphthalene
11/30/2011	CN101289424B 一类具有高抗球虫活性和促进生长双重功效的喹酯类化合物 A class of quinoline esters with high anticoccidial activity and promote the growth of double effect
11/29/2011	US8067602 Asymmetric cyanine fluorescent dyes, compositions and their use in staining biological samples
11/29/2011	US8067600 Histone deacetylase inhibitors and methods of use thereof
11/29/2011	US8067592 N-alkyny-2-(substituted aryloxy) alkylthioamine derivatives as fungicides
11/29/2011	US8067438 Hepatitis C inhibitor compounds
11/29/2011	US8067437 Beta-2-adrenoreceptor agonists
11/29/2011	US8067436 c-Met modulators and methods of use
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2479786C Quinoline derivatives and their use as 5-ht6 ligands
11/24/2011	WO2011146886A1 Processes for producing modulators of cystic fibrosis transmembrane conductance regulator
11/24/2011	WO2011146618A1 Inhibitors of human 12-lipoxygenase
11/24/2011	WO2011145669A1 Amide derivative
11/24/2011	US20110288121 Processes for Producing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
11/24/2011	US20110288117 Substituted hydroxamic acids and uses thereof
11/24/2011	US20110288111 Inhibition of influenza m2 proton channel
11/24/2011	US20110287937 Ring-fused 2-pyridone derivatives and herbicides
11/24/2011	US20110286922 Imaging and radiotherapy methods
11/24/2011	CA2800143A1 Selective hdac inhibitors
11/24/2011	CA2799792A1 Inhibitors of human 12-lipoxygenase
11/23/2011	EP2387563A1 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer
11/23/2011	EP2387562A1 Quinolinone derivatives useful for the treatment of cns disorders
11/23/2011	EP2387561A2 Improved process for the preparation of highly pure (3r,5s)-7-ý2-cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl¨-3,5-dihydroxy-6(e)-heptenoic acid and pharmaceutically acceptable salts thereof
11/23/2011	CN102250103A Synthesis method of SN38 or intermediate thereof
11/23/2011	CN102249997A Group of 4-substituted phenylaminoquinoline compounds having antitumor activity
11/23/2011	CN102249996A 2-(quinoline-8-yl)carbonyl-cyclohexane-1,3-dione compounds
11/23/2011	CN101193853B Anthranilic acid derivatives
11/23/2011	CN101044135B Quinoline derivatives
11/22/2011	US8063222 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/22/2011	US8063221 Aminoquinolones as GSK-3 inhibitors
11/22/2011	US8063220 Sulfonyl-quinoline derivatives
11/22/2011	US8063200 Labeled compound and detection method using the same
11/22/2011	US8063067 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/22/2011	US8063066 MAPK/ERK kinase inhibitors
11/22/2011	US8063049 Inhibitors of MEK
11/22/2011	US8063046 Benzamide derivative
11/22/2011	CA2653830C 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
11/22/2011	CA2534838C Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative
11/17/2011	WO2011143105A1 Bifunctional quinoline derivatives
11/17/2011	WO2011140829A1 Solid supported gold nanoparticles, methods of use thereof, and methods for making same
11/17/2011	WO2011140682A1 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
11/17/2011	WO2011140680A1 Urea compounds and use thereof for inhibiting apoptosis
11/17/2011	WO2011140599A1 Chemical compound arrays useful for detecting bacterial peptides
11/17/2011	WO2011087815A3 Deuterated zirconium compound for electronic applications
11/17/2011	US20110282065 Solid supported gold nanoparticles, methods of use thereof, and methods for making same
11/17/2011	US20110281909 Substituted quinoline derivatives as h1 receptor antagonists
11/17/2011	US20110281908 Aminoquinoline Derived Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
11/17/2011	US20110281898 Phenoxiacetic acid derivatives
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281851 Biphenyl compounds useful as muscarinic receptor antagonists
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants
11/17/2011	US20110281356 Compounds for stem cell differentiation
11/17/2011	US20110281290 Sox-based kinase sensor
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2007728B1 A process for preparing tetrahydroquinoline derivatives
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	CN102245733A Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/16/2011	CN102241629A Chemical preparation method of norfloxacin
11/16/2011	CN102241628A (2E)-3-phenyl-N-[2,2,2-trichlorine-1-[[(8-quinolyl amino) thiomethyl]amino]ethyl]-2-acrylamide and medicinal uses thereof
11/16/2011	CN102241627A Carbamide compound and its medicinal usage
11/16/2011	CN101516852B Quinoline derivatives with 5-ht-binding properties
11/16/2011	CN101212973B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/16/2011	CN101171234B Dihydropyridine derivatives
11/15/2011	US8058474 Urea derivative and process for preparing the same
11/15/2011	US8058442 Neuroprotective iron chelators and pharmaceutical compositions comprising them
11/15/2011	US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011	US8058307 Alcanoic acid amides substituted by saturated O-heterocycles
11/15/2011	CA2517033C Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist
11/10/2011	WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011	US20110275792 Metal coordinated compositions
11/10/2011	US20110275668 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient
11/10/2011	US20110275643 Aroylquinoline compounds
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275622 Bi-functional quinoline analogs
11/09/2011	EP2139881B1 Quinolines and their therapeutic use
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1667675B1 Entry inhibitors of the hiv virus
11/09/2011	CN102239149A Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
11/09/2011	CN102239148A Methods of preparing quinoline derivatives
11/09/2011	CN102239147A Quinolone compound and pharmaceutical composition
11/09/2011	CN102238951A Pharmaceutical agent comprising quinolone compound
11/09/2011	CN102234271A Aryl (alkyl) amino dithio formate compounds, and preparation method and application thereof
11/09/2011	CN101857602B Preparation method for Prulifloxacin
11/09/2011	CN101838237B Clean production process for separating 8-hydroxyquinoline from quinoline method neutralizing solution
11/09/2011	CN101638385B Novel carbostyril derivative and preparation and application thereof
11/09/2011	CN101492477B Photosensitizer, composite photocatalyst and method for preparing the same
11/09/2011	CN101260078B Method for preparing 7,8-dihydroquinolin-5(6H)-ones derivatives
11/08/2011	US8053445 Utilities of olefin derivatives
11/03/2011	WO2011137089A1 Activators of human pyruvate kinase
11/03/2011	WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011	WO2011134098A1 Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline
11/03/2011	US20110269962 Process for preparing statins
11/03/2011	US20110269793 Method for preventing tau protein aggregation and treating alzheimer's disease with a quinoline derivative compound
11/03/2011	US20110269785 Substituted 2-Aminoacetamides and the Use Thereof
11/03/2011	US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments

1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 277